期刊文献+

加味桃红四物汤治疗视网膜静脉阻塞的疗效观察 被引量:5

下载PDF
导出
摘要 目的评价加味桃红四物汤治疗视网膜静脉阻塞的临床疗效。方法50例视网膜静脉阻塞患者分为两组,26例(26眼)为治疗组采用加味桃红四物汤治疗,24例(24眼)为对照组采用静滴丹参注射液治疗。结果加味桃红四物治疗总有效率84.62%,高于对照组;治疗组眼底出血、渗出吸收总有效率为96.15%,高于对照组。
作者 曹平 苏露煜
出处 《现代中医药》 CAS 2009年第4期54-55,共2页 Modern Chinese Medicine
  • 相关文献

参考文献2

二级参考文献28

  • 1张惠蓉.视网膜分支静脉阻塞和新生血管形成[J].中华眼底病杂志,1994,10(2):67-70. 被引量:25
  • 2张惠蓉 李凤鸣.黄斑囊样水肿荧光造影和病理研究[J].眼科学报,1985,1:151-151.
  • 3[1]瘳品正主编.中医眼科学.上海:上海科学技术出版社,1986.116~119.
  • 4[2]Hayreh SS, klygman MR, Beri M, et al. Differentiation of ischemic from nonischenic central retinal vein occlusion during the early acute phase. Graefs Arch Clin Exp Ophthahmal, 1990, 228:201~217.
  • 5Michael L, Murat T, John K, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology, 2002, 109: 126-131.
  • 6Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb,2002, 32(5-6) :308-311.
  • 7Prisco D, Marcucci R, Bertini L, et al. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med, 2002, 13:163-169.
  • 8Lahey JM, Kearney JJ, Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med, 2003, 9:385-392.
  • 9Van Cott EM, Laposata M, Hartnett ME. Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis, 2004, 15:393-397.
  • 10Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost,2001, 86:772-776.

共引文献10

同被引文献90

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部